February 20, 2019
Published: Oct 16, 2018 By Mark Terry Discovery Life Sciences, a leading research biobank located in Los Osos, California, recently got much, much bigger via a four-company merger. Ann […]
February 18, 2019
February 18, 2019, 22:00 CET – Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that […]
February 4, 2019
Amsterdam, the Netherlands, and Holzgerlingen, Germany, February 04, 2019, 08:00 am CET – Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of […]
January 30, 2019
Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 30, 2019; published at 08:00 a.m. CET — Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a […]
January 8, 2019
Ares Genetics to start EUR 1.3 million TRIPLE-A development project co-funded by Vienna Business Agency Initiates set-up of R&D and service laboratory in Vienna Vienna, Austria, […]
December 19, 2018
> Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform > Collaboration leverages Ares Genetics’ antibiotic resistance database ARESdb > Short-term focus on repurposing existing […]
October 25, 2018
The Economist / Science and Technology, Sep 20th 2018 ONE tale of Nasreddin, a self-satirising 13th-century philosopher, tells of the time he lost a precious ring. […]
October 12, 2018
NEW YORK (GenomeWeb) – Curetis announced today that it has extended an exclusive distribution agreement with Beijing Clear Biotech (BCB), expanding it from five years to […]
September 7, 2018
https://theconversation.com/discovering-the-ancient-origin-of-cystic-fibrosis-the-most-common-genetic-disease-in-caucasians-100499 Imagine the thrill of discovery when more than 10 years of research on the origin of a common genetic disease, cystic fibrosis (CF), results in […]
